BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
12.30
+0.45 (3.80%)
Oct 20, 2025, 3:50 PM EDT - Market open
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,644,492
Market Cap
22.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jul 31, 2023 | 16 | 10 | 166.67% |
Jul 31, 2021 | 6 | 0 | - |
Aug 1, 2019 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BCTX News
- 8 hours ago - BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025 - GlobeNewsWire
- 7 days ago - BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 - GlobeNewsWire
- 17 days ago - BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting - GlobeNewsWire
- 7 weeks ago - BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal - GlobeNewsWire
- 2 months ago - BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer - GlobeNewsWire
- 2 months ago - BriaCell Announces Proposed Effective Date of Share Consolidation - GlobeNewsWire
- 2 months ago - BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer - GlobeNewsWire
- 2 months ago - BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - GlobeNewsWire